Improving Treatment Outcomes for Non-Seminomatous Germ Cell Tumours
Author Information
Author(s): Bono J S de, Paul J, Simpson A, Anthoney A, Kirk D, Underwood M, Graham J, Kaye S B
Primary Institution: Departments of Medical Oncology, University of Glasgow
Hypothesis
The study investigates the effectiveness of salvage treatment strategies for patients with relapsed non-seminomatous germ cell tumours.
Conclusion
The study indicates an improving outlook for patients with relapsed non-seminomatous germ cell tumours, especially those treated surgically.
Supporting Evidence
- 41 patients were treated for relapsed non-seminomatous germ cell tumours.
- 57% of patients requiring chemotherapy remain alive.
- 50% of patients are disease free after treatment.
- 59% of patients treated with chemotherapy and surgery have no evaluable disease.
- 36% of patients treated with chemotherapy alone remain alive.
Takeaway
This study looked at how well patients with a specific type of cancer did after their treatment didn't work. It found that some treatments are getting better.
Methodology
The study analyzed treatment outcomes for 41 patients with relapsed non-seminomatous germ cell tumours over a period from 1991 to 1996.
Participant Demographics
Patients treated between 1991 and 1996 for relapsed non-seminomatous germ cell tumours.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website